Ann: AGM Presentation, page-120

Outlook '24 is great but that is the ST problem for the sp. Market won't expect anything exciting until Feb / Mar. Last year's JPM conference didn't help despite "Her-Vaxx being the star", why should it be different this time in Jan'24.

If we are lucky we get a PD1-Vaxx anns as mentioned by LC sometime between now and ? and / or an Her-Vaxx deal anns. But as Her-Vaxx is still in a clinical trial stage and just got moved to Taiwan that could still take some time. As mentioned by LC, any Vaxinia update will be made at the next major conference but I doubt the JPM conference is the one they choose as it just a few weeks away.

Therefore, due to the usual X-MAS period news slow down and all the big ones just announced I expect the sp to drift sub10c and to hover around that 9c-10c mark, until we get significant updates. And red markets, despite being the X-MAS colour, won't help either.

Anyway, LT outlook great, ST outlook could be a little bit subdued.

GLTA